Evidence map›Paper›PMID 41188425›Full record

ArticleScientific reports2025

Dietary oregano essential oil and sodium butyrate enhance growth, immunity, and gene expression in nile tilapia post-Aeromonas hydrophila infection.

Eman M Moustafa, Mustafa Shukry, Mona Assas, Haguer M Salah El Din, Mohamed A Khallaf, Hanan A Ghetas, Azza Hafez, Foad Farrag, Asmaa T Mousa, Wesam H Marzouk

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Hydralazine potentiates the antiproliferative effect of photodynamic therapy on Candida albicans and Candida parapsilosis in vitro.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2026
    Article
  2. Biology · 2026
    Article
  3. Article
  4. DietaryFrontiers in immunology · 2026
    Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Eman M MoustafaFish Diseases and Management Department, Faculty of Veterinary Medicine, Faculty of veterinary medicine, Kafrelsheikh University, Kafrelsheikh, Egypt. emantarek2002@yahoo.com.
Mustafa ShukryAnimal Physiology Department, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt. mostafa.ataa@vet.kfs.edu.eg.
Mona AssasFish processing and Biotechnology department, Faculty of Aquatic Fishes, Kafrelsheikh University, Kafrelsheikh, Egypt.
Haguer M Salah El DinFish Diseases and Management Department, Faculty of Veterinary Medicine, Faculty of veterinary medicine, Kafrelsheikh University, Kafrelsheikh, Egypt.
Mohamed A KhallafAquatic Animals Medicine and Management Department, Faculty of Veterinary Medicine, Sadat University, Sadat City, 32897, Egypt.
Hanan A GhetasAquatic Animals Medicine and Management Department, Faculty of Veterinary Medicine, Sadat University, Sadat City, 32897, Egypt.
Azza HafezNutrition and Clinical Nutrition Department, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt.
Foad FarragAnatomy and embryology department, Faculty of Veterinary Medicine, Kafrelsheikh University, Kafrelsheikh, Egypt.
Asmaa T MousaFish Diseases and Management Department, Faculty of Veterinary Medicine, Faculty of veterinary medicine, Kafrelsheikh University, Kafrelsheikh, Egypt.
Wesam H MarzoukVeterinarian at the General Organization for Veterinary Services in Cairo, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The impacts of oregano essential oil and sodium butyrate on the growth performance, hematological, biochemical, immunological, antioxidative, and gene expression profiles of Nile tilapia (Oreochromis niloticus) fingerlings were examined in this study. One hundred eighty healthy fingerlings (16.00 ± 2.00 g) were acclimated and accidentally divided into three groups, each further split into three replicates. The groups were fed a basal diet (control) or diets supplemented with 0.5% and 1% oregano essential oil and sodium butyrate for eight weeks (The feed additives were administered continuously throughout an 8-week trial period, simulating a practical feeding strategy that would be feasible during high-risk periods (e.g., post-handling stress, seasonal disease outbreaks). Fish fed the supplemented diets demonstrated significantly greater growth performance, with the oregano 1% + sodium butyrate 1% group achieving the highest final body weight (36.91 ± 0.66 g) and lowest feed conversion ratio (1.32 ± 0.04). Hematological indices, including RBC count, Hb, and PCV, were substantially improved. Biochemical analysis revealed reduced ALT, AST, urea, and creatinine levels alongside elevated total protein and globulin concentrations in treated groups. Immunological and antioxidative parameters, such as WBC count, phagocytic activity, SOD, and GPX, showed significant enhancements, particularly in the oregano 1% + sodium butyrate 1% group. Gene expression analysis exposed upregulation of immune-related (TNF-α, IL-1β) and antioxidative (SOD, GPX) genes in supplemented groups, highlighting their role in enhancing health and stress responses. Post Aeromonas hydrophila infection, the supplemented groups exhibited improved immunity, antioxidative status, and survival. These findings suggest that dietary supplementation with oregano essential oil and sodium butyrate, particularly at 1% inclusion, effectively enhances growth, health status, immunity, and gene expression in Nile tilapia.

Indexed as

Aeromonas hydrophilaButyric AcidCichlidsFish DiseasesGram-Negative Bacterial InfectionsOils, VolatileOriganumAnimal FeedAnimalsDietary SupplementsGene Expression RegulationButyric AcidOils, VolatileAeromonas hydrophilaAntioxidative responseGrowth performanceImmunity enhancementNile tilapiaOregano essential oilSodium butyrate

Identifiers

PMID41188425
PMCPMC12586456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.